ADVERTISEMENT
There’s More To Syngene Stock Surge Than Remdesivir Supply Pact
Shares of Syngene International have surged nearly threefold in the last six months, beating all benchmarks and peers.
08 Oct 2020, 07:59 AM IST
Shares of Syngene International Ltd. have surged nearly threefold in the last six months, beating all benchmarks and peers, as the contract researcher signed pacts to make a drug used in severe cases of Covid-19, scaled up capacity and added clients.The stock now trades at a record of Rs 597 apiece, rising 190% since the global equity selloff triggered by the pandemic in March. That compares with a twofold jump in the Nifty Pharma In...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT